Conversely, samples with lower SUCLG2 expression were enriched in pathways related to epithelial–mesenchymal transition and inflammatory responses, highlighting the multifaceted roles of SUCLG2 in tumor biology (Figure 4C). The gene discussed is SUCLG2; the disease is neoplasm.